We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
Cap. Flow
+$1.23B
Cap. Flow %
3.55%
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332

Top Buys

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$342M
2
INTC icon
Intel
INTC
+$276M
3
TSM icon
TSMC
TSM
+$237M
4
PG icon
Procter & Gamble
PG
+$178M
5
JPM icon
JPMorgan Chase
JPM
+$170M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$383M
2
OXY icon
Occidental Petroleum
OXY
+$321M
3
PYPL icon
PayPal
PYPL
+$316M
4
SPGI icon
S&P Global
SPGI
+$145M
5
DDOG icon
Datadog
DDOG
+$133M

Sector Composition

Rank Sector Weight
1 Technology 26.57%
2 Healthcare 17.95%
3 Financials 9.89%
4 Industrials 9.61%
5 Consumer Discretionary 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAV
2401
DELISTED
Aravive, Inc. Common Stock
ARAV
$35K ﹤0.01%
43,115
-35,333
-45% -$30.4K
ABSI icon
2402
Absci
ABSI
$1.21B
$34K ﹤0.01%
+10,800
New +$39.7K
CLLS
2403
Cellectis
CLLS
$286M
$34K ﹤0.01%
14,900
-400
-3% -$1.21K
OVID icon
2404
Ovid Therapeutics
OVID
$440M
$34K ﹤0.01%
18,300
-5,500
-23% -$11.5K
VXRT
2405
DELISTED
Vaxart
VXRT
$34K ﹤0.01%
+15,500
New +$53.5K
XERS icon
2406
Xeris Biopharma Holdings
XERS
$1.42B
$34K ﹤0.01%
22,100
-43,700
-66% -$72.3K
CO
2407
DELISTED
Global Cord Blood Corporation
CO
$34K ﹤0.01%
11,400
– –
ADAP
2408
DELISTED
Adaptimmune Therapeutics
ADAP
$33K ﹤0.01%
31,100
-4,200
-12% -$7.72K
XNET
2409
Xunlei
XNET
$334M
$33K ﹤0.01%
23,400
-20,200
-46% -$31.9K
COOK icon
2410
Traeger
COOK
$164M
$32K ﹤0.01%
224
-756
-77% -$128K
GOTU icon
2411
Gaotu Techedu
GOTU
$384M
$32K ﹤0.01%
26,400
-106,200
-80% -$172K
AMS icon
2412
American Shared Hospital Services
AMS
$10.5M
$31K ﹤0.01%
11,800
– –
AWX icon
2413
Avalon Holdings
AWX
$10.1M
$31K ﹤0.01%
11,700
– –
CYCN icon
2414
Cyclerion Therapeutics
CYCN
$15.2M
$31K ﹤0.01%
1,830
-3,005
-62% -$51.6K
DMAC icon
2415
DiaMedica Therapeutics
DMAC
$358M
$31K ﹤0.01%
24,900
-1,800
-7% -$2.81K
ASM
2416
Avino Silver & Gold Mines
ASM
$964M
$30K ﹤0.01%
58,700
-19,700
-25% -$11.1K
RVLP
2417
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$30K ﹤0.01%
14,100
-3,300
-19% -$6.41K
MTCR
2418
DELISTED
Metacrine, Inc. Common Stock
MTCR
$30K ﹤0.01%
62,500
-25,400
-29% -$12.5K
BGMS
2419
Bio Green Med Solution Inc
BGMS
$4.94M
$29K ﹤0.01%
6
+1
+20% +$5.08K
LVO icon
2420
LiveOne
LVO
$64.8M
$29K ﹤0.01%
4,060
+590
+17% +$6.23K
PAYS icon
2421
Paysign
PAYS
$510M
$29K ﹤0.01%
12,300
– –
CRGE
2422
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$29K ﹤0.01%
+16,700
New +$47.6K
HYRE
2423
DELISTED
HyreCar Inc. Common Stock
HYRE
$29K ﹤0.01%
31,400
-13,300
-30% -$12.4K
AGTC
2424
DELISTED
Applied Genetic Technologies Corporation
AGTC
$28K ﹤0.01%
104,749
+60,700
+138% +$26.5K
CURI icon
2425
CuriosityStream
CURI
$145M
$27K ﹤0.01%
18,700
+2,000
+12% +$3.51K
95 96
97
98 99

Similar funds

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
VRS
Virginia Retirement Systems Richmond, Virginia $16.8B AUM 25.91% 1-Year Est. Return
FAF
Första AP-fonden Stockholm, Sweden $16.8B AUM 29.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
CIM
CCLA Investment Management London, United Kingdom $6.23B AUM 5.02% 1-Year Est. Return
PPFA
Provida Pension Fund Administrator Las Condes, Santiago, Chile $5.78B AUM 21.16% 1-Year Est. Return

Two Sigma Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.

  • Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
  • Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
  • Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
  • Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
  • Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
  • Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
  • Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.